Agile Therapeutics to Participate in Maxim Group’s Leading Innovators in Women’s Health Virtual Conference
August 11 2020 - 4:02PM
Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare
company, today announced that Al Altomari, Chairman and Chief
Executive Officer, will participate in a panel discussion as part
of Maxim Group’s M-Vest Virtual Conference Series: Leading
Innovators in Women’s Health, beginning at 10:00 a.m. Eastern Time
on Thursday, August 13, 2020. The panel will be moderated by Jason
McCarthy, PhD, lead biotechnology analyst at Maxim Group.
Webcast Details:
- Date and Time: Thursday, August
13, 10:00 a.m. Eastern time
- Registration Link: https://bit.ly/2DlgeRW
About Agile Therapeutics,
Inc.Agile Therapeutics is a women's healthcare
company dedicated to fulfilling the unmet health needs of today’s
women. Our product candidates are designed to provide women
with contraceptive options that offer freedom from taking a daily
pill, without committing to a longer-acting method. Our
initial product, Twirla®, (levonorgestrel and ethinyl estradiol)
transdermal system is a non-daily prescription contraceptive.
Twirla is based on our proprietary transdermal patch technology,
called Skinfusion®, which is designed to allow drug delivery
through the skin. For more information, please visit the company
website at www.agiletherapeutics.com. The
Company may occasionally disseminate material, nonpublic
information on the Company’s website.
Follow Agile on LinkedIn and
Twitter: @AgileTher.
Contact: Matt RileyHead
of Investor Relationsmriley@agiletherapeutics.com
Agile Therapeutics (NASDAQ:AGRX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Agile Therapeutics (NASDAQ:AGRX)
Historical Stock Chart
From Apr 2023 to Apr 2024